WINTON GROUP Ltd decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 75.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,744 shares of the company’s stock after selling 86,583 shares during the quarter. WINTON GROUP Ltd’s holdings in Henry Schein were worth $1,865,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Captrust Financial Advisors acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $141,000. Advisory Services Network LLC grew its stake in shares of Henry Schein by 430.1% during the 4th quarter. Advisory Services Network LLC now owns 2,099 shares of the company’s stock worth $147,000 after purchasing an additional 1,703 shares during the period. Fuller & Thaler Asset Management Inc. grew its stake in shares of Henry Schein by 100.0% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,400 shares of the company’s stock worth $168,000 after purchasing an additional 1,200 shares during the period. IBM Retirement Fund acquired a new stake in shares of Henry Schein during the 1st quarter worth approximately $232,000. Finally, Lee Financial Co grew its stake in shares of Henry Schein by 100.0% during the 1st quarter. Lee Financial Co now owns 3,512 shares of the company’s stock worth $236,000 after purchasing an additional 1,756 shares during the period. 96.65% of the stock is currently owned by institutional investors and hedge funds.
Shares of Henry Schein opened at $74.54 on Tuesday, MarketBeat reports. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.74 and a current ratio of 1.44. The company has a market cap of $11.50 billion, a PE ratio of 20.71, a price-to-earnings-growth ratio of 1.78 and a beta of 1.00. Henry Schein, Inc. has a 1 year low of $62.56 and a 1 year high of $93.14.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 8th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.03. The company had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.18 billion. Henry Schein had a return on equity of 19.68% and a net margin of 3.18%. The firm’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.88 EPS. sell-side analysts expect that Henry Schein, Inc. will post 4.1 EPS for the current fiscal year.
HSIC has been the topic of a number of analyst reports. Bank of America initiated coverage on shares of Henry Schein in a research note on Tuesday, February 27th. They set a “neutral” rating and a $76.00 price objective on the stock. BidaskClub cut shares of Henry Schein from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 1st. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, March 6th. Barclays initiated coverage on Henry Schein in a research report on Thursday, March 8th. They set an “equal weight” rating and a $71.00 target price on the stock. Finally, Leerink Swann upgraded Henry Schein from a “market perform” rating to an “outperform” rating and set a $75.00 target price on the stock in a research report on Wednesday, April 4th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $81.59.
In other Henry Schein news, EVP Mark E. Mlotek sold 10,359 shares of the firm’s stock in a transaction on Tuesday, June 12th. The stock was sold at an average price of $72.73, for a total value of $753,410.07. Following the transaction, the executive vice president now owns 79,506 shares in the company, valued at approximately $5,782,471.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Paul Brons sold 4,822 shares of the firm’s stock in a transaction on Monday, June 11th. The shares were sold at an average price of $72.93, for a total value of $351,668.46. Following the completion of the transaction, the director now owns 20,889 shares in the company, valued at approximately $1,523,434.77. The disclosure for this sale can be found here. Company insiders own 1.15% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.